BRIDGET EHRHART-BENNETT: Open Payments
NPI 1851609549 · WHEELERSBURG, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$995 in 54 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $281 · 2025 $995
Food & beverage: $995
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $411 |
| Vanda Pharmaceuticals Inc. | 14 | $198 |
| Axsome Therapeutics, Inc. | 9 | $166 |
| Otsuka America Pharmaceutical, Inc. | 3 | $49 |
| Collegium Pharmaceutical, Inc. | 2 | $43 |
| Teva Pharmaceuticals USA, Inc. | 2 | $43 |
| Janssen Pharmaceuticals, Inc | 2 | $38 |
| Neurocrine BioSciences, Inc. | 1 | $18 |
| Indivior Inc. | 1 | $16 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 |
Products named: VRAYLAR, Auvelity, FANAPT, HETLIOZ, REXULTI, Jornay PM, AUSTEDO XR, INVEGA SUSTENNA.
Industry payments across OH — which companies pay providers there.
